4//SEC Filing
Burke William Patrick 4
Accession 0001645113-23-000026
CIK 0001645113other
Filed
Mar 1, 7:00 PM ET
Accepted
Mar 2, 4:51 PM ET
Size
9.0 KB
Accession
0001645113-23-000026
Insider Transaction Report
Form 4
NovoCure LtdNVCR
Burke William Patrick
Chief Human Resources Officer
Transactions
- Award
Ordinary Shares
2023-02-28+12,125→ 67,719 total - Award
Options to Buy Ordinary Shares
2023-02-28$76.97/sh+20,168$1,552,331→ 20,168 totalExercise: $76.97From: 2024-02-28Exp: 2033-02-27→ Ordinary Shares (20,168 underlying) - Sale
Ordinary Shares
2023-03-01$76.36/sh−755$57,654→ 66,964 total
Footnotes (3)
- [F1]Represents restricted share units that are scheduled to vest in equal installments on February 28, 2024, 2025 and 2026, subject to the reporting person's continued employment through such dates.
- [F2]Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units. This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.
- [F3]Options to buy 20,168 ordinary shares will vest and become exercisable in equal installments on each of February 28, 2024, 2025, 2026 and 2027, subject to the reporting person's continued employment through such dates.
Documents
Issuer
NovoCure Ltd
CIK 0001645113
Entity typeother
Related Parties
1- filerCIK 0001880493
Filing Metadata
- Form type
- 4
- Filed
- Mar 1, 7:00 PM ET
- Accepted
- Mar 2, 4:51 PM ET
- Size
- 9.0 KB